Literature DB >> 1737833

Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix.

U Saxena1, M G Klein, T M Vanni, I J Goldberg.   

Abstract

Lipoprotein lipase (LPL), the rate-limiting enzyme for hydrolysis of plasma lipoprotein triglycerides, is a normal constituent of the arterial wall. We explored whether LPL affects (a) lipoprotein transport across bovine aortic endothelial cells or (b) lipoprotein binding to subendothelial cell matrix (retention). When bovine milk LPL was added to endothelial cell monolayers before addition of 125I-labeled LDL, LDL transport across the monolayers was unchanged; but, at all concentrations of LDL tested (1-100 micrograms), LDL retention by the monolayers increased more than fourfold. 125I-labeled LDL binding to extracellular matrix increased when LPL was added directly to the matrix or was added to the basolateral side of the endothelial cell monolayers. Increased LDL binding required the presence of LPL and was not associated with LDL aggregation. LPL also increased VLDL, but not HDL, retention. Monoclonal anti-LPL IgG decreased both VLDL and LDL retention in the presence of LPL. Lipoprotein transport across the monolayers increased during hydrolysis of VLDL triglyceride (TG). In the presence of LPL and VLDL, VLDL transport across the monolayers increased 18% and LDL transport increased 37%. High molar concentrations of oleic acid to bovine serum albumin (3:1) in the medium increased VLDL transport approximately 30%. LDL transport increased 42% when oleic acid was added to the media. Therefore, LPL primarily increased retention of LDL and VLDL. A less remarkable increase in lipoprotein transport was found during hydrolysis of TG-containing lipoproteins. We hypothesize that LPL-mediated VLDL and LDL retention within the arterial wall potentiates conversion of these lipoproteins to more atherogenic forms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737833      PMCID: PMC442862          DOI: 10.1172/JCI115595

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

Review 2.  Arterial wall proteoglycans--biological properties related to pathogenesis of atherosclerosis.

Authors:  B Radhakrishnamurthy; S R Srinivasan; P Vijayagopal; G S Berenson
Journal:  Eur Heart J       Date:  1990-08       Impact factor: 29.983

Review 3.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

4.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries.

Authors:  D C Schwenke; T E Carew
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

5.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

Review 6.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

7.  Transport of lipoprotein lipase across endothelial cells.

Authors:  U Saxena; M G Klein; I J Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

8.  Human apolipoprotein B-100 heparin-binding sites.

Authors:  K H Weisgraber; S C Rall
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

9.  Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids.

Authors:  U Saxena; L D Witte; I J Goldberg
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

10.  Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages.

Authors:  L Jonasson; G Bondjers; G K Hansson
Journal:  J Lipid Res       Date:  1987-04       Impact factor: 5.922

View more
  26 in total

1.  Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation.

Authors:  Michael J Walters; Steven P Wrenn
Journal:  J Colloid Interface Sci       Date:  2011-07-28       Impact factor: 8.128

2.  Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.

Authors:  M Shimada; S Ishibashi; T Inaba; H Yagyu; K Harada; J I Osuga; K Ohashi; Y Yazaki; N Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Not the mature 56 kDa lipoprotein lipase protein but a 37 kDa protein co-purifying with the lipase mediates the binding of low density lipoproteins to J774 macrophages.

Authors:  W L Hendriks; L C Van Vark; K Schoonderwoerd; H Jansen; L M Havekes
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 4.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

5.  Characterization of an atypical lipoprotein-binding protein in human aortic media membranes by ligand blotting.

Authors:  Y S Kuzmenko; V N Bochkov; M P Philippova; V A Tkachuk; T J Resink
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

6.  Lipoprotein lipase regulates Fc receptor-mediated phagocytosis by macrophages maintained in glucose-deficient medium.

Authors:  B Yin; J D Loike; Y Kako; P H Weinstock; J L Breslow; S C Silverstein; I J Goldberg
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

7.  Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response.

Authors:  Alvaro Pulchinelli; Ana Maria Massad Costa; Cristina V de Carvalho; Naiara Correa Nogueira de Souza; Mauro A Haidar; Adagmar Andriolo; Ismael D C Guerreiro da Silva
Journal:  Lipids Health Dis       Date:  2011-11-02       Impact factor: 3.876

8.  Lipoprotein Lipase Deficiency Impairs Bone Marrow Myelopoiesis and Reduces Circulating Monocyte Levels.

Authors:  Chuchun L Chang; Itsaso Garcia-Arcos; Rakel Nyrén; Gunilla Olivecrona; Ji Young Kim; Yunying Hu; Rishi R Agrawal; Andrew J Murphy; Ira J Goldberg; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

9.  Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages.

Authors:  S C Rumsey; J C Obunike; Y Arad; R J Deckelbaum; I J Goldberg
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.

Authors:  Zengxuan Nong; Herminia Gonzalez-Navarro; Marcelo Amar; Lita Freeman; Catherine Knapper; Edward B Neufeld; Beverly J Paigen; Robert F Hoyt; Jamila Fruchart-Najib; Silvia Santamarina-Fojo
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.